Impact of human papillomavirus status on survival in patients with oral cancer
- PMID: 38867852
- PMCID: PMC11168070
- DOI: 10.1002/lio2.1294
Impact of human papillomavirus status on survival in patients with oral cancer
Abstract
Objectives: To examine the association between the human papillomavirus (HPV) infection and overall survival rate in patients with oral cancer.
Methods: This retrospective cohort study examined HPV status in 454 patients who were diagnosed with oral squamous cell carcinoma (OSCC) using the records of patients who underwent an initial treatment for OSCC between 2012 and 2021 at our institution as retrieved from the Cancer Registry database. The survival rates of the HPV-positive and HPV-negative groups were assessed and compared, and independent factors associated with survival were analyzed using multivariate Cox regression models.
Results: Of the 454 patients with OSCC included in this study, 73 were excluded for invalid HPV tests. Of the remaining patients, 39 and 342 patients were categorized into HPV-positive and HPV-negative groups, respectively. The prevalence of HPV-positive in the patients with OSCC was 10.2% (95% confidence interval 7.2%-13.2%). The 3-year overall survival rates were 56.2% and 53.9% in the HPV-positive and HPV-negative groups, respectively. The 3-year disease-specific survival rates in the HPV-positive and HPV-negative groups were 60.2% and 56.9%, respectively. The survival differences were not statistically significant. HPV-positive status was not a significant predictor of overall survival in the multivariable Cox regression analyses (p = 0.728).
Conclusion: The prevalence of HPV-positivity among patients with OSCC in the study was 10.2%. No association was found between HPV-positive status and 3-year overall survival in patients with oral cancer.
Level of evidence: Level 3.
Keywords: human papillomavirus; oral cancer; prevalence; survival rate.
© 2024 The Author(s). Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Similar articles
-
Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.Oncol Res Treat. 2017;40(6):320-327. doi: 10.1159/000477097. Epub 2017 May 17. Oncol Res Treat. 2017. PMID: 28558385
-
Double Positivity for HPV DNA/P16INK4a Does Not Influence Survival of Patients With Oral Squamous Cell Carcinoma.Anticancer Res. 2021 Nov;41(11):5557-5568. doi: 10.21873/anticanres.15369. Anticancer Res. 2021. PMID: 34732426
-
A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.Cancer Med. 2017 May;6(5):910-917. doi: 10.1002/cam4.1045. Epub 2017 Apr 4. Cancer Med. 2017. PMID: 28378539 Free PMC article.
-
Association between human papillomavirus and oral cancer: a literature review.Int J Clin Oncol. 2023 Aug;28(8):982-989. doi: 10.1007/s10147-023-02327-9. Epub 2023 Mar 17. Int J Clin Oncol. 2023. PMID: 36929094 Review.
-
An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and prevention.Anticancer Res. 2011 May;31(5):1515-9. Anticancer Res. 2011. PMID: 21617204 Review.
References
LinkOut - more resources
Full Text Sources
Research Materials